أعرض في EDS

EE156 Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure (HF) with Preserved Ejection Fraction (HFPEF) in France, Based on Emperor-Preserved Clinical Trial

التفاصيل البيبلوغرافية
العنوان:	EE156 Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure (HF) with Preserved Ejection Fraction (HFPEF) in France, Based on Emperor-Preserved Clinical Trial
المؤلفون:	P Levy, N Lamblin, H Groyer, J Chollet, J Tardu, S Linden, L Fauchier
المصدر:	Value in Health. 25:S83
بيانات النشر:	Elsevier BV, 2022.
سنة النشر:	2022
مصطلحات موضوعية:	Health Policy, Public Health, Environmental and Occupational Health
تدمد:	1098-3015
DOI:	10.1016/j.jval.2022.09.406
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::d96b3f384e5f8ff55c40b56a70a9c027 https://doi.org/10.1016/j.jval.2022.09.406
Rights:	CLOSED
رقم الانضمام:	edsair.doi...........d96b3f384e5f8ff55c40b56a70a9c027
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	10983015
DOI:	10.1016/j.jval.2022.09.406